HUNTINGTON NATIONAL BANK - Valeant Pharmaceuticals ownership

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of Valeant Pharmaceuticals
ValueSharesWeighting
Q4 2009$51,000
+13.3%
1,6060.0%0.00%0.0%
Q3 2009$45,000
+9.8%
1,6060.0%0.00%0.0%
Q2 2009$41,000
+41.4%
1,6060.0%0.00%0.0%
Q1 2009$29,0001,6060.00%
Other shareholders
Valeant Pharmaceuticals shareholders Q3 2023
NameSharesValueWeighting ↓
BAXTER BROS INC 19,900$317,0000.09%
CULLINAN ASSOCIATES INC 46,000$732,0000.06%
Sonora Investment Management, LLC 360$5,731,0000.00%
View complete list of Valeant Pharmaceuticals shareholders